Julia Lainster

The SOHO-01 trial results highlight that gastrointestinal and skin-related issues such as diarrhea and rash are the most common side effects, which are generally considered manageable by clinicians. On August 24, 2026, Japan’s Ministry of Health, Labour and Welfare reached a landmark decision by

Sponsors of CNS-directed gene therapies are now being urged to embed independent imaging review boards directly into their trial protocols to avoid similar regulatory failures. This directive follows the U.S. Food and Drug Administration's decision to issue a second clinical hold on Regenxbio’s

Laboratories specializing in virology and immunology must now evaluate if their current biosafety margins are sufficient to protect staff from aerosolized H5N1 exposure. The recent isolation of live, infectious H5N1 avian influenza from a commercial batch of fetal bovine serum (FBS) has sparked a

Dr. Colleen Clancy is pioneering the use of Optical Digital Twins to bridge the gap between complex biological data and individualized medical interventions. This mission stands at the heart of the Center for Precision Medicine and Data Sciences at UC Davis Health, where the convergence of advanced

For centuries, the sight of multiple individuals resting in a single medieval grave was interpreted by archaeologists as a poignant snapshot of a family unit, perhaps a mother and child or siblings, bound together even in death. This romanticized view suggested that the biological nuclear family

Medical wireless alarm systems function as an automated safety net by utilizing a complex network of sensors and transmitters to monitor patient health metrics in real time. This technological framework replaces the cumbersome wiring of the past, allowing for a more dynamic and responsive clinical

Identifying CD31 protein expression in engineered tissue constructs serves as a vital indicator that a functional internal blood vessel network has begun to take shape. For patients grappling with catastrophic bone injuries or the aftermath of tumor removals, the quest for a permanent solution

Improving the safety and efficacy of new medical treatments requires a shift toward research tools that are grounded in human biology and actual patient cell responses. The traditional paradigm of pharmaceutical development has long relied on animal models, which frequently fail to predict human

Genomic data provided through expanded testing allowed 14.5 percent of patients to transition to safer treatment options, significantly reducing the risks of therapy-related complications and morbidity. This breakthrough underscores a fundamental shift in the oncological landscape, where the focus

Automated robotic systems at facilities like the Living Measurement Systems Foundry are now essential for removing human error and generating the high-fidelity data needed for scientific discovery. Professor Chris Myers, a prominent researcher from the University of Colorado Boulder, has